Application

17211071 · PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO

Filed 2021-03-24 · Granted · Patent 11911390 (2024-02-27) The official file ↗The patent and its PDF ↗ · Art unit 1615 · Examiner Shirley V Gembeh Easy · CPC A61K 31/53 · Respira Therapeutics, Inc. · HAUG PARTNERS LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

22.0 mo

to disposition 35.2 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.